Supernus Pharm (SUPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 408,897 | 302,238 | 215,003 | 147,465 | 92,678 |
| Cost of Goods | 15,356 | 15,215 | 11,986 | 8,423 | 5,758 |
| Gross Profit | 393,541 | 287,023 | 203,017 | 139,042 | 86,920 |
| Operating Expenses | 249,453 | 187,697 | 149,787 | 118,621 | 92,956 |
| Operating Income | 144,444 | 99,541 | 54,216 | 20,844 | -5,278 |
| Interest Expense | 18,111 | 1,568 | 5,091 | 4,770 | 5,621 |
| Other Income | 13,843 | 2,645 | 1,244 | -1,464 | 604 |
| Pre-tax Income | 140,176 | 100,618 | 50,369 | 14,610 | -10,295 |
| Income Tax | 29,183 | 43,334 | -40,852 | 666 | 630 |
| Net Income Continuous | 110,993 | 57,284 | 91,221 | 13,944 | -10,925 |
| Net Income | $110,993 | $57,284 | $91,221 | $13,944 | $-10,925 |
| EPS Basic Total Ops | 2.13 | 1.13 | 1.84 | 0.29 | -0.26 |
| EPS Basic Continuous Ops | 2.13 | 1.13 | 1.84 | 0.29 | -0.26 |
| EPS Diluted Total Ops | 2.05 | 1.08 | 1.76 | 0.28 | -0.26 |
| EPS Diluted Continuous Ops | 2.05 | 1.07 | 1.76 | 0.27 | -0.26 |
| EPS Diluted Before Non-Recurring Items | 2.05 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $161,690 | $107,160 | $57,135 | $22,513 | $-2,260 |